Polyp of ethmoidal sinus

Summary

Polyp of ethmoidal sinus (MONDO:0021418) is a disease and 1 clinical trial. A subtype of paranasal sinus disorder — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Clinical trials: 1

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	polyp of ethmoidal sinus
Mondo ID	MONDO:0021418
NCIT	C3932
SNOMED CT	23966000
UMLS	C0264248
MedGen	82675
Anatomy (UBERON)	UBERON:0002453
Is cancer (heuristic)	no

Also known as: ethmoid sinus polyp · ethmoidal polyp · ethmoidal sinus polyp · polyp of ethmoid sinus · polyp of the ethmoid sinus · polyp of the ethmoidal sinus

Disease family

This is a subtype of paranasal sinus disorder. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › otorhinolaryngologic disease › nasal disorder › paranasal sinus disorder › polyp of ethmoidal sinus

Related subtypes (6): paranasal sinus neoplasm, sinusitis, maxillary sinus cholesteatoma, polyp of sphenoidal sinus, polyp of frontal sinus, polyp of maxillary sinus

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 1.

Phase distribution (across all retrieved trials)

Phase	Trials
Not specified	1

Top trials by phase / activity

NCT	Phase	Status	Title
NCT02559284	Not specified	COMPLETED	RESPIMER® Netiflow® vs. Saline Solutions During Nasal Irrigation Following Bilateral Ethmoidectomy (Nasal Polyposis)